Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evofem Biosciences Inc (NQ: EVFM )

0.4782 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.4782
Bid (Size) 0.4405 (85)
Ask (Size) 0.4450 (126)
Prev. Close 0.4782
Today's Range 0.4782 - 0.4782
52wk Range 0.2750 - 8.040
Shares Outstanding 155,208,456
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Evofem Biosciences's Return On Capital Employed Insights
 
Via Benzinga
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 5.56% in November, recording two subsequent monthly increases for the first time in 2022. 
Via Benzinga

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-37.88%
-37.88%
1 Year
-92.95%
-92.95%

More News

Read More
Why Evofem Biosciences Shares Are Plunging Today?
Via Benzinga
4 Analysts Have This to Say About Evofem Biosciences
Via Benzinga
Evofem Biosciences Phase 3 EVOGUARD Trial Puts October Catalyst In Play, Here’s Why Investors Are Paying Attention ($EVFM)
Via AB Newswire
Evofem Clocks 42% Growth For Its On-Demand Birth Control Product
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Via Benzinga
Evofem Biosciences Return On Capital Employed Overview
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Traders News Source Senior Editor, Mark Roberts Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier
Via ACCESSWIRE
Evofem Biosciences Stock Jumps 185% Since June…Here’s Why Its FDA-Approved Phexxi May Add Appreciably To Those Gains In 2/H 2022 ($EVFM)
Via AB Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Marker Therapeutics Trading Higher By 119%: Here Are 42 Stocks Moving Premarket
Via Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Via Benzinga
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Evofem Biosciences Discusses Innovative Woman-Controlled Contraceptive with The Stock Day Podcast
Via Newsfile
Exposures Product Safety
5 Short Squeeze Stocks That May Soar: ToughBuilt, Blue Hat And This Streaming Company
Via Benzinga
Netflix And 15 Stocks Moving Premarket
Via Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Via Benzinga
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.